Literature DB >> 15240663

Tec kinase migrates to the T cell-APC interface independently of its pleckstrin homology domain.

Fabien Garçon1, Georges Bismuth, Daniel Isnardon, Daniel Olive, Jacques A Nunès.   

Abstract

Tec is the prototypical member of the Tec tyrosine kinases family, which plays an important role in T cell signaling. We show in this study that Tec translocates to the immunological synapse when a T cell contacts a dendritic cell. Surprisingly, the presence of the pleckstrin homology (PH) domain of Tec is not required for this accumulation, and despite a strong activation of 3'-phosphorylated phosphoinositide lipids synthesis during the synapse formation, the Tec PH domain is not redistributed to the T cell plasma membrane. In contrast, we demonstrate that an active Src homology 3 domain is absolutely required, underlining the essential role played by this part of the molecule in the recruitment and/or stabilization of Tec at the immunological synapse. Our results nevertheless suggest that the PH domain controls the kinase activity of the molecule in vivo. We finally demonstrate that the two domains are necessary to trigger transcriptional events following Ag presentation. These data support a model in which the plasma membrane recruitment of the PH-containing protein Tec is not dependent on the production of 3'-phosphorylated phosphoinositide lipids by the PI3K, but rather on an intact Src homology 3 domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240663     DOI: 10.4049/jimmunol.173.2.770

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Tec kinase mediating IL-8 transcription in monocytes stimulated with LPS.

Authors:  Guang-Qing Wang; Xiao-Yan Yang; Yi-Tao Jia; Zhao-Fan Xia
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

2.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.